Thus, we hypothesize that under the condition of IDO1 deficiency, TDO increases in the liver to compensate, which can decrease the proliferation of Th17 cells in CCl4-induced liver fibrosis. This evidence concerns the gene IDO1 and Hepatic fibrosis.